Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Knowing when to prioritize financial planning over investment planning can significantly impact your financial success. Find the right balance for your goals.
25,635 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Navan stock soared today as the company posted solid growth and highlighted AI-driven efficiencies in its platform. T...
A pivotal AI funding milestone shifts how investors view tech giants. Learn what the Anthropic move signals for Amazo...
Bitcoin moves into July with mixed signals from the price chart and macro headlines. Here's what history says about J...
Investors are weighing Hut 8 and Riot Platforms as data-center developers expanding beyond Bitcoin mining. This guide...
As the SaaS crowd sinks, AI-powered software names may rise to the occasion in 2026. This article explains why and po...
Oil tensions linked to Iran have put pressure on stocks, lifting energy prices and weighing on the S&P 500 and Nasdaq...
The Trade Desk faced another slide as investors weighed AI-driven competition and fee pressure. This deep dive breaks...
When energy costs rise, investors often look for EV players that could benefit. This article unpack Rivian's path to ...
Tech leadership returned to the forefront as semiconductors boosted Nasdaq in July trading. This article breaks down ...
Dorman's 2025 earnings narrative hinges on aftermarket demand, margins, and strategic bets. This guide breaks down wh...
Germany faces a policy crossroads: broaden the VAT base to shift the burden from labor to consumption. This article b...